Results 161 to 170 of about 751,468 (329)

The Case for High Returns: A Study of the U.S. Pharmaceutical Industry [PDF]

, 1995
In recent years, the pharmaceutical industry has undergone intense criticism from a myriad of opponents from President Clinton to the common citizen.
Taylor \u2795, David
core   +1 more source

Support System for Pharmaceutical Management and Counseling Services for Rational Use of Medication. (No 2). Database of the Pharmaceutical Standard Care.

, 1999
Hitomi Teramachi, Tetsuo Hattori, MISAO HATTORI, Miki Yoshida, HUMIKA KATO, Miho Hotta, Hiromi Yamashita, Yukio Imai   +7 more
openalex   +2 more sources

Role of pharmacy organizations in transforming the profession: The case of pharmaceutical care [PDF]

, 2001
William A. Zellmer
openalex   +1 more source

Hydrogen‐Bubble Repellent Conjugated Polymeric Coating for Improving Electrochemical Hydrogen Evolution.

Advanced Functional Materials, EarlyView.
A hydrogen‐bubble repellent conjugated polymeric coating improves an electrochemical hydrogen evolution reaction maintaining a lower overpotential, a highly electrochemically active surface area and smaller Tafel slope. While the hydrogen‐bubble repellence because of polyglycerol moiety ensures an early detachment of produced hydrogen gas bubbles, the ...
Jaysri Das, Esra Özdemir, Hrisikesh Sarma, Andreas Terfort, Uttam Manna   +4 more
wiley   +1 more source

Market Structure and Drug Innovation [PDF]

An explosion of knowledge and a growing array of tools and technologies have transformed modern drug R&D, while its cost has risen by a sizable amount.
Pammolli, Fabio, Riccaboni, Massimo
core   +1 more source

The Cost of High Prices: Embedding an Ethic of Expense into the Standard of Care [PDF]

, 2017
In the midst of rapid and radical change of America’s health care system, the country’s crown jewel public health insurance program, Medicare, faces an intensifying cost crisis due to a past of uncontrolled prices and a future of booming enrollment.
Buck, Isaac D.
core  

TPP3: PHARMACEUTICAL CARE AND HEALTH CARE UTILIZATION

, 1999
Fischer Lr, T. A. Defor, S. P. Cooper, Lynn M. Scott, Diann M. Boonstra, Marilyn A. Eelkema, K Hase, Marcus Goodman   +7 more
openalex   +1 more source

Individualized health care and the pharmaceutical industry [PDF]

, 2001
Gary Epler, Lewis L. Laskaris
openalex   +1 more source

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, EarlyView.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Identification of the need for pharmaceutical care within the prevention strategy of CHD: a study in acute MI patients [PDF]

, 2001
Surarong Chinwong, Fiona Reid, Steve McGlynn, Steve Hudson, Andy D. Flapan   +4 more
openalex   +1 more source